Hepatocellular adenoma future or investigational therapies: Difference between revisions
Nawal Muazam (talk | contribs) No edit summary |
Mahshid |
||
| Line 19: | Line 19: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Surgery]] | |||
[[Category:Hepatology]] | |||
Latest revision as of 01:58, 27 November 2017
|
Hepatocellular adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hepatocellular adenoma future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Hepatocellular adenoma future or investigational therapies |
|
FDA on Hepatocellular adenoma future or investigational therapies |
|
CDC on Hepatocellular adenoma future or investigational therapies |
|
Hepatocellular adenoma future or investigational therapies in the news |
|
Blogs on Hepatocellular adenoma future or investigational therapies |
|
Risk calculators and risk factors for Hepatocellular adenoma future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
Hepatocellular adenoma future or investigational therapies
Hepatic arterial embolization is new approach for patients who develop acute haemorrhage due to rupture of the hepatocellular adenoma.[1]
References
- ↑ Ault GT, Wren SM, Ralls PW, Reynolds TB, Stain SC (1996). "Selective management of hepatic adenomas". Am Surg. 62 (10): 825–9. PMID 8813164.